Back
Phathom Pharmaceuticals Vs. Gorman-Rupp Industry Stock Comparison
Buy
76
PHAT
Phathom Pharmaceuticals
Last Price:
10.53
Seasonality Move:
10.39%
Buy
66
GRC
Gorman-Rupp
Last Price:
32.55
Seasonality Move:
1.42%
Buy
76
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $10.54. The Score for PHAT is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Gorman-Rupp (GRC)
is a Buy
Is Gorman-Rupp a Buy, Sell or Hold?
- The current Gorman-Rupp [GRC] share price is $32.60. The Score for GRC is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- GRC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $10.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing slight buying pressure.
GRC Stock Price Chart
What is Gorman-Rupp's stock price today?
-
The Gorman-Rupp share price today is $32.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRC is experiencing buying pressure, which is a positive indicator for future bullish movement.
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 57.05 | Buy |
| Chaikin Money Flow: | 56950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.18 - 10.32) | Buy |
| Bollinger Bands (100): | (7.64 - 10.48) | Buy |
GRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.94 | Sell |
| Relative Strength Index (14 RSI): | 37.3 | Sell |
| Chaikin Money Flow: | 54153 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.28 - 35.6) | Sell |
| Bollinger Bands (100): | (33.38 - 37.66) | Sell |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.18 | Buy |
| 20-day SMA: | 9.77 | Buy |
| 50-day SMA: | 9.8 | Buy |
| 200-day SMA: | 9.82 | Buy |
| 8-day EMA: | 10.27 | Buy |
| 20-day EMA: | 10.04 | Buy |
| 50-day EMA: | 9.76 | Buy |
| 200-day EMA: | 9.76 | Buy |
GRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.94 | Sell |
| 20-day SMA: | 33.37 | Sell |
| 50-day SMA: | 35.99 | Sell |
| 200-day SMA: | 33.73 | Sell |
| 8-day EMA: | 32.86 | Sell |
| 20-day EMA: | 33.61 | Sell |
| 50-day EMA: | 34.87 | Sell |
| 200-day EMA: | 33.59 | Sell |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.34 per share, a decrease this year of $1.15 per share, and an increase next year of $1.18 per share.
Gorman-Rupp Earnings Growth & GRC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.08 per share, an increase this year of $0.27 per share, and an increase next year of $0.32 per share.
Phathom Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gorman-Rupp Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||